Anti‐PD1 monoclonal antibodies vs chemotherapy aloneToxicity (≥ G3) · people with cutaneous melanoma1 finding from 1 reviewSystemic treatments for metastatic cutaneous melanoma 2018 · Cochrane Headline outcomes only0.55 [0.31, 0.97]1360 participantsLow